Hims & Hers Health Shares Slip Over 7% in Pre-Market Trading Following Q4 Revenue Miss

Stock News02-24 22:30

Hims & Hers Health Inc. (HIMS.US) shares fell more than 7% in pre-market trading on Tuesday, reaching $14.40. The decline followed the company's report of its financial results for the fourth quarter of 2025. Revenue for the quarter was $617.82 million, representing a 28% year-over-year increase but falling short of the expected $619.22 million. Earnings per share came in at $0.08, surpassing the forecast of $0.03. The number of subscribers exceeded 2.5 million; however, the gross margin narrowed to 72% from 77% a year earlier. For the first quarter, the company provided revenue guidance in the range of $600 million to $625 million, which is below the consensus estimate of $653.12 million. For the full 2026 fiscal year, Hims & Hers Health anticipates revenue between $2.7 billion and $2.9 billion, compared to a market expectation of $2.74 billion.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment